Ryan K. Lanier

659 total citations
29 papers, 488 citations indexed

About

Ryan K. Lanier is a scholar working on Public Health, Environmental and Occupational Health, Physiology and Pharmacology. According to data from OpenAlex, Ryan K. Lanier has authored 29 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 8 papers in Physiology and 5 papers in Pharmacology. Recurrent topics in Ryan K. Lanier's work include Pain Mechanisms and Treatments (6 papers), Opioid Use Disorder Treatment (6 papers) and Pain Management and Placebo Effect (5 papers). Ryan K. Lanier is often cited by papers focused on Pain Mechanisms and Treatments (6 papers), Opioid Use Disorder Treatment (6 papers) and Pain Management and Placebo Effect (5 papers). Ryan K. Lanier collaborates with scholars based in United States, United Kingdom and Israel. Ryan K. Lanier's co-authors include George E. Bigelow, Eric C. Strain, Miriam Z. Mintzer, Michelle R. Lofwall, Nathaniel P. Katz, Curtis Wright, Oluwadolapo D. Lawal, Nathalie Erpelding, Roi Treister and Annie Umbricht and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Ryan K. Lanier

29 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan K. Lanier United States 14 140 122 93 92 82 29 488
Mohamed A. Khalil Egypt 11 93 0.7× 118 1.0× 78 0.8× 91 1.0× 53 0.6× 46 637
Hans Bijl Netherlands 7 205 1.5× 155 1.3× 73 0.8× 228 2.5× 64 0.8× 7 538
Patricia Risède France 16 123 0.9× 186 1.5× 91 1.0× 80 0.9× 125 1.5× 35 633
Rutger van der Schrier Netherlands 12 100 0.7× 114 0.9× 58 0.6× 145 1.6× 98 1.2× 31 529
Eveline van Dorp Netherlands 10 75 0.5× 196 1.6× 57 0.6× 129 1.4× 62 0.8× 14 440
Judy Ashworth United States 11 137 1.0× 159 1.3× 127 1.4× 120 1.3× 28 0.3× 15 430
Manzumeh Shamsi Meymandi Iran 17 170 1.2× 79 0.6× 48 0.5× 24 0.3× 71 0.9× 53 562
Jörg Filitz Germany 7 250 1.8× 62 0.5× 166 1.8× 135 1.5× 41 0.5× 12 420
Anne Roussin France 16 58 0.4× 146 1.2× 99 1.1× 102 1.1× 167 2.0× 42 696
Dragana Srebro Serbia 11 174 1.2× 47 0.4× 255 2.7× 77 0.8× 58 0.7× 36 583

Countries citing papers authored by Ryan K. Lanier

Since Specialization
Citations

This map shows the geographic impact of Ryan K. Lanier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan K. Lanier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan K. Lanier more than expected).

Fields of papers citing papers by Ryan K. Lanier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan K. Lanier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan K. Lanier. The network helps show where Ryan K. Lanier may publish in the future.

Co-authorship network of co-authors of Ryan K. Lanier

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan K. Lanier. A scholar is included among the top collaborators of Ryan K. Lanier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan K. Lanier. Ryan K. Lanier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zia, Farah, Michael H. Baumann, Robert H. Dworkin, et al.. (2023). Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs. Neuropharmacology. 233. 109528–109528. 18 indexed citations
2.
Henningfield, Jack E., David V. Gauvin, Francesco Bifari, et al.. (2022). REL-1017 (esmethadone; d-methadone) does not cause reinforcing effect, physical dependence and withdrawal signs in Sprague Dawley rats. Scientific Reports. 12(1). 11389–11389. 10 indexed citations
3.
4.
As‐Sanie, Sawsan, Ahmed M. Soliman, Kathryn Evans, et al.. (2020). Short-acting and Long-acting Opioids Utilization among Women Diagnosed with Endometriosis in the United States: A Population-based Claims Study. Journal of Minimally Invasive Gynecology. 28(2). 297–306.e2. 13 indexed citations
5.
As‐Sanie, Sawsan, et al.. (2019). PIH48 A RETROSPECTIVE DATABASE ANALYSIS OF SHORT-ACTING AND LONG-ACTING OPIOID USE IN WOMEN WITH ENDOMETRIOSIS: II-PATTERNS OF UTILIZATION. Value in Health. 22. S190–S190. 1 indexed citations
6.
Harry, John R., et al.. (2019). Focus of attention effects on lower extremity biomechanics during vertical jump landings. Human Movement Science. 68. 102521–102521. 15 indexed citations
7.
8.
Lawal, Oluwadolapo D., et al.. (2018). Medication errors involving intravenous patient-controlled analgesia: results from the 2005–2015 MEDMARX database. Therapeutic Advances in Drug Safety. 9(8). 389–404. 11 indexed citations
9.
10.
Lanier, Ryan K., et al.. (2017). (468) Interventions to reduce the placebo response in clinical trials: a review of the literature. Journal of Pain. 18(4). S90–S90. 2 indexed citations
11.
Lanier, Ryan K., Reginald V. Fant, Edward J. Cone, & Jack E. Henningfield. (2017). Assessment of the abuse potential and benefits of kratom and its mitragynine alkaloids: Implications for regulation. Drug and Alcohol Dependence. 171. e114–e114. 3 indexed citations
12.
Caine, S. Barak, Gregory T. Collins, Morgane Thomsen, et al.. (2014). Nicotine-like behavioral effects of the minor tobacco alkaloids nornicotine, anabasine, and anatabine in male rodents.. Experimental and Clinical Psychopharmacology. 22(1). 9–22. 52 indexed citations
13.
14.
Duke, Angela N., George E. Bigelow, Ryan K. Lanier, & Eric C. Strain. (2011). Discriminative Stimulus Effects of Tramadol in Humans. Journal of Pharmacology and Experimental Therapeutics. 338(1). 255–262. 37 indexed citations
15.
Mintzer, Miriam Z., Ryan K. Lanier, Michelle R. Lofwall, George E. Bigelow, & Eric C. Strain. (2010). Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers. Drug and Alcohol Dependence. 111(3). 265–268. 31 indexed citations
16.
Lanier, Ryan K., Michelle R. Lofwall, Miriam Z. Mintzer, George E. Bigelow, & Eric C. Strain. (2010). Physical dependence potential of daily tramadol dosing in humans. Psychopharmacology. 211(4). 457–466. 63 indexed citations
17.
Bauer, Kenneth A., Curtis Wright, Ewan D McNicol, et al.. (2010). Platelet function following administration of a novel formulation of intravenous diclofenac sodium versus active comparators: a randomized, single dose, crossover study in healthy male volunteers. Journal of Clinical Anesthesia. 22(7). 510–518. 25 indexed citations
18.
Tompkins, D. Andrew, et al.. (2010). Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone. Psychopharmacology. 210(4). 471–480. 24 indexed citations
19.
Lanier, Ryan K., et al.. (2008). Opioid detoxification via single 7-day application of a buprenorphine transdermal patch: an open-label evaluation. Psychopharmacology. 198(2). 149–158. 20 indexed citations
20.
Lanier, Ryan K., et al.. (2002). Self-administration of heroin produces alterations in the expression of inducible nitric oxide synthase. Drug and Alcohol Dependence. 66(3). 225–233. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohamed A. Khalil Breakdown of academic impact, for papers by Hans Bijl Breakdown of academic impact, for papers by Patricia Risède Breakdown of academic impact, for papers by Rutger van der Schrier Breakdown of academic impact, for papers by Eveline van Dorp Breakdown of academic impact, for papers by Judy Ashworth Breakdown of academic impact, for papers by Manzumeh Shamsi Meymandi Breakdown of academic impact, for papers by Jörg Filitz Breakdown of academic impact, for papers by Anne Roussin Breakdown of academic impact, for papers by Dragana Srebro
Rankless by CCL
2026